Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Heliosynthese and Scotia receive EEC Eureka award for microalgae research

July 12, 1996

Phytera and Tsumura Juntendo collaborate in rheumatoid arthritis/allergy R&D

July 12, 1996

Collaboration on signal transduction inhibitor drug discovery announced

July 12, 1996

Arris issued U.S. patent for drug design technology

July 12, 1996

Arris, SKB to research protease inhibitors

July 5, 1996

ArQule, ICAgen collaborate on ion channel modulators

July 5, 1996

Gilead reports important discovery related to genetic code blocker research

July 5, 1996

Eotaxin receptor cloned: Possible implications for asthma research

July 5, 1996

Anergen, Organon to collaborate on RA treatment

July 5, 1996

ArQule obtains rights to Yale's alpha-ketoamide chemistry technology

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...